<?xml version='1.0' encoding='utf-8'?>
<document id="22535491"><sentence text="Evaluation of drug-drug interaction screening software combined with pharmacist intervention." /><sentence text="Drug-drug interactions (DDI) in hospitalized patients are highly prevalent and an important source of adverse drug reactions" /><sentence text=" DI computerized screening system can prevent the occurrence of some of these events" /><sentence text="" /><sentence text="To evaluate the impact of drug-drug interaction (DDI) screening software combined with active intervention in preventing drug interactions" /><sentence text="" /><sentence text="The study was conducted at General Hospital of VitÃ³ria da Conquista (HGVC), Brazil" /><sentence text="" /><sentence text="A quasi-experimental study was used to evaluate the impact of IM-Pharma, a locally developed drug-drug interaction screening system, coupled with pharmacist intervention on adverse drug events in the hospital setting" /><sentence text="" /><sentence text="The proportion of patients co-prescribed two interacting drugs were measured in two phases, prior the implementation of IM-Pharma and during the intervention period" /><sentence text=" DDI rates per 100 patient days were calculated before and after implementation" /><sentence text=" Risk ratios were estimated by Poisson regression models" /><sentence text="" /><sentence text="A total of 6,834 instances of drug-drug interactions were identified; there was an average of 3" /><sentence text="3 DDIs per patient in phase one and 2" /><sentence text="5 in phase two, a reduction of 24 % (P = 0" /><sentence text="03)" /><sentence text=" There was a 71 % reduction in high-severity drug-drug interaction (P &lt; 0" /><sentence text="01)" /><sentence text=" The risk for all DDIs decreased 50 % after the implementation of IM-Pharma (P &lt; 0" /><sentence text="01), and for those with high-severity, the reduction was 81 % (P &lt; 0" /><sentence text="01)" /><sentence text="" /><sentence text="The performance of IM-Pharma combined with pharmacist intervention was positive with an expressive reduction in the risk of DDIs" /><sentence text="" /></document>